Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Cleveland › NPI 1811069685
Lab

The Cleveland Clinic Foundation

The Cleveland Clinic Foundation was paid $9.04M by Medicaid between Jan 2018 and Dec 2024, across 228 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 25% of everything it billed.

33Billing provider infoTHE CLEVELAND CLINIC FOUNDATION
CLEVELAND, OH 44195
33aNPI1811069685assigned 11/15/2006
33bProvider typeClinical Medical Laboratory
28Total paid$9.04M
24GClaims1,029,241
24DCodes billed228
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Ohio

Rank by total paid#18 of 116
Median peer was paid$313K
This provider vs. median29×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018117,093$904K
2019157,640$975K
2020173,181$1.69M
2021225,932$3.10M
2022139,443$1.10M
2023109,746$634K
2024incomplete106,206$639K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 25% 36,006 22,937 $2.22M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 5.6% 25,498 15,871 $508K
80053 Comprehensive metabolic panel 5.6% 72,534 64,293 $504K
84443 Thyroid stimulating hormone (TSH) 4.8% 45,049 42,839 $431K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4.6% 33,635 32,162 $416K
80061 Lipid panel 4.1% 46,151 44,158 $368K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.6% 67,092 55,933 $321K
36415 Collection of venous blood by venipuncture 3.1% 162,261 110,133 $282K
87631 3.1% 2,906 2,756 $278K
80048 Basic metabolic panel (calcium, ionized) 2.3% 54,672 35,038 $207K
83036 Hemoglobin; glycosylated (A1C) 2.2% 37,585 35,876 $195K
85027 2.0% 59,611 42,800 $177K
216 more codes
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.4% 4,840 $126K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.4% 4,867 $124K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.4% 895 $123K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 2,782 $108K
82607 1.1% 13,112 $102K
86480 1.0% 2,358 $92K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 3,849 $90K
83970 <1% 3,678 $80K
G0475 Hiv antigen/antibody, combination assay, screening <1% 6,612 $77K
86235 <1% 2,502 $71K
84439 <1% 12,914 $68K
87086 Culture, bacterial; quantitative colony count, urine <1% 15,421 $63K
82728 <1% 7,283 $60K
83735 <1% 15,818 $54K
86803 <1% 5,102 $49K
87522 Neg quan hep c or qual rna <1% 2,385 $44K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,427 $43K
86780 <1% 4,265 $43K
83655 <1% 3,946 $43K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,760 $42K
80069 <1% 10,386 $42K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 2,334 $42K
83550 <1% 7,780 $41K
87077 <1% 9,485 $41K
80050 General health panel <1% 2,344 $40K
84153 <1% 3,409 $38K
84403 <1% 2,105 $36K
82043 <1% 9,539 $36K
82570 <1% 11,251 $35K
87340 <1% 4,947 $35K
80076 <1% 6,889 $35K
83540 <1% 8,527 $34K
86140 <1% 10,562 $33K
85610 <1% 20,971 $33K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 628 $33K
84702 <1% 3,138 $32K
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel <1% 1,339 $31K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 2,064 $31K
80074 <1% 1,791 $31K
86147 <1% 572 $31K
87186 <1% 7,231 $29K
83880 <1% 1,471 $28K
81001 <1% 15,245 $27K
82746 <1% 3,362 $27K
86038 <1% 3,008 $26K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,210 $26K
84480 <1% 2,595 $24K
84481 <1% 1,938 $23K
84146 <1% 1,561 $21K
84550 <1% 6,501 $19K
83516 <1% 1,664 $19K
87660 <1% 1,203 $18K
84402 <1% 996 $18K
82784 <1% 1,946 $18K
85652 <1% 9,886 $18K
87480 <1% 1,187 $17K
87510 <1% 1,187 $17K
87070 <1% 3,014 $17K
86334 <1% 994 $17K
82565 <1% 4,447 $16K
86762 <1% 1,440 $15K
86706 <1% 1,732 $13K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 653 $13K
84100 <1% 4,248 $12K
87493 <1% 821 $12K
80164 <1% 1,914 $12K
86255 <1% 893 $12K
87505 <1% 197 $12K
83001 <1% 812 $12K
86003 <1% 547 $11K
83690 <1% 2,420 $11K
87205 <1% 3,686 $11K
83721 <1% 1,933 $10K
86592 <1% 2,986 $10K
87536 <1% 178 $10K
80197 <1% 1,137 $10K
86431 <1% 2,159 $9K
80202 <1% 1,089 $9K
86704 <1% 1,054 $9K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 1,564 $8K
82150 <1% 1,844 $8K
82550 <1% 1,715 $8K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 200 $8K
84436 <1% 2,278 $7K
86709 <1% 926 $7K
86200 <1% 718 $7K
82105 <1% 675 $7K
84156 <1% 3,102 $7K
82248 <1% 1,937 $7K
86376 <1% 616 $7K
84460 <1% 2,010 $7K
86705 <1% 700 $7K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 78 $7K
83002 <1% 533 $6K
85018 <1% 2,763 $6K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 146 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 354 $6K
82274 <1% 476 $6K
86850 <1% 1,124 $5K
82670 <1% 277 $5K
82140 <1% 599 $5K
85730 <1% 1,330 $5K
86225 <1% 530 $5K
82977 <1% 939 $5K
87653 <1% 260 $4K
88342 <1% 186 $4K
81003 <1% 4,091 $4K
84450 <1% 1,212 $4K
87808 <1% 405 $4K
88141 <1% 214 $4K
86708 <1% 459 $4K
86359 <1% 160 $4K
80177 <1% 604 $4K
86141 <1% 444 $4K
82947 <1% 1,403 $3K
86364 <1% 369 $3K
81374 <1% 107 $3K
82950 <1% 1,036 $3K
86160 <1% 294 $3K
86696 <1% 196 $3K
87497 <1% 110 $3K
84134 <1% 338 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 57 $3K
88341 <1% 53 $2K
82533 <1% 208 $2K
84154 <1% 211 $2K
86900 <1% 1,069 $2K
86901 <1% 1,068 $2K
82627 <1% 147 $2K
88321 <1% 91 $2K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 46 $2K
82652 <1% 87 $2K
86665 <1% 129 $2K
85379 <1% 393 $2K
84132 <1% 719 $2K
84630 <1% 220 $2K
86695 <1% 198 $2K
80178 <1% 332 $2K
86812 <1% 61 $1K
88142 <1% 92 $1K
82378 <1% 87 $1K
86361 <1% 70 $1K
86146 <1% 29 $1K
84520 <1% 481 $1K
99214 Doctor's office visit, returning patient (more involved) <1% 72 $996.18
86800 <1% 77 $953.51
86258 <1% 97 $942.72
84165 <1% 135 $936.00
83615 <1% 216 $865.19
84155 <1% 396 $852.92
85732 <1% 100 $736.66
84425 <1% 49 $674.32
85390 <1% 73 $642.70
86765 <1% 67 $641.05
82677 <1% 44 $635.28
99213 Doctor's office visit, returning patient (routine) <1% 26 $573.47
84144 <1% 39 $570.12
86336 <1% 56 $535.95
85597 <1% 38 $535.85
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 24 $525.45
87529 <1% 29 $520.02
82785 <1% 37 $497.81
85613 <1% 78 $489.44
85045 <1% 137 $405.32
84478 <1% 99 $400.31
86735 <1% 43 $392.07
80185 <1% 52 $372.30
80364 <1% 26 $364.05
80361 <1% 26 $364.05
82465 <1% 108 $332.50
87799 <1% 14 $330.96
86787 <1% 35 $316.82
80358 <1% 38 $312.46
86381 <1% 18 $304.44
82330 <1% 25 $291.75
80365 <1% 38 $290.18
86039 <1% 37 $283.41
83520 <1% 22 $261.85
83525 <1% 32 $253.29
85060 <1% 19 $240.63
82040 <1% 121 $234.71
80162 <1% 37 $225.10
80373 <1% 26 $224.40
85670 <1% 52 $218.48
80349 <1% 26 $202.12
80324 <1% 26 $202.12
80353 <1% 26 $202.12
80348 <1% 26 $202.12
80356 <1% 26 $202.12
80354 <1% 26 $202.12
83090 <1% 16 $191.19
84075 <1% 81 $182.07
82103 <1% 40 $179.52
86677 <1% 12 $172.46
83883 <1% 14 $166.09
87481 <1% 37 $165.84
86015 <1% 28 $162.68
82747 <1% 12 $156.65
86317 <1% 13 $141.60
87338 <1% 12 $139.12
85520 <1% 15 $137.52
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 31 $136.80
G0452 Molecular pathology procedure; physician interpretation and report <1% 19 $136.65
86663 <1% 13 $135.00
82310 <1% 64 $132.12
82525 <1% 14 $127.13
84295 <1% 60 $104.14
82374 <1% 60 $101.72
82435 <1% 64 $99.51
82247 <1% 49 $86.34
85014 <1% 62 $80.08
87088 <1% 13 $79.32
84484 <1% 16 $59.86
86694 <1% 13 $35.61
3074F 0% 34 $0.00
3078F 0% 43 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER)
Same official

Other billing entities under LARAWAY, DENNIS

Full network →
ProviderLocationPaid
The Cleveland Clinic FoundationCleveland, OH$863.55M
Akron General Medical CenterAkron, OH$98.99M
Cleveland Clinic Mercy HospitalCanton, OH$86.97M
Memorial Hermann Health SystemHouston, TX$84.45M
Fairview HospitalCleveland, OH$62.42M
Lutheran HospitalCleveland, OH$41.49M
Cleveland Clinic Health System - East RegionEuclid, OH$40.67M
Memorial Hermann Health SystemHouston, TX$39.46M
Cleveland Clinic Children's Hospital for RehabilitationCleveland, OH$36.43M
Cleveland Clinic Health System - East RegionMayfield Hts, OH$32.76M
Cleveland Clinic Health System - East RegionWarrensville Heights, OH$31.44M
Partners Physician GroupAkron, OH$28.37M
Marymount Hospital INCGarfield Heights, OH$28.02M
Memorial Hermann Health SystemHumble, TX$26.79M
Martin Memorial Medical Center INCStuart, FL$26.03M
The Union Hospital AssociationDover, OH$20.23M
Lodi Community HospitalLodi, OH$17.53M
Clinic Medical Services Company LLCCleveland, OH$10.82M
Cleveland Clinic Home Care ServicesIndependence, OH$10.76M
Indian River Memorial Hospital INCVero Beach, FL$9.27M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.